Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Advertising and Promotion

Advertising and Promotion

                        Modified Risk Tobacco Products Home
          Tobacco Products
          Products, Guidance & Regulations
          Advertising and Promotion
          22nd Century Group Inc. Modified Risk Tobacco Product (MRTP) ApplicationsAdvertising and Promotion 22nd Century Group Inc. Modified Risk Tobacco Product (MRTP) Applications
  
  	
    Share
    Post
    Linkedin

    Email
    PrintOn December 23, 2021, FDA issued exposure modification orders to 22nd Century Group Inc. for VLN® King and VLN® Menthol King combusted, filtered cigarettes. The orders specifically authorize the manufacturer to market these products with certain reduced exposure claims regarding nicotine.

See the Modified Risk Granted Orders webpage for order letters and decision summaries relevant to these actions.

Please sign up to receive email alerts when any MRTP application materials are made publicly available or check this webpage regularly. The latest set of application materials from 22nd Century Group Inc. were updated on **February 22, 2021**.

The application materials below have been redacted in accordance with applicable laws.

***Temporary Compliance Waiver:** The linked files may not be fully accessible to readers using assistive technology. We regret any inconvenience that this may cause. In the event you are unable to read these documents or portions thereof, please email AskCTP@fda.hhs.gov or call 1-877-287-1373.*

Originally Submitted Application:

FOIA Cover Letter (PDF – 33 KB) – posted July 19, 2019
	Section I Cover Letter(PDF - 500 MB) – posted July 19, 2019
	Section II Contents (zip – 2 MB) – updated October 26, 2020Section III Executive Summary – updated August 28, 2019
	Part 1 Executive Summary (PDF – 2.9 MB) – posted July 19, 2019

Part 2 Published Literature (zip – 1 MB) posted August 28, 2019

Part 3 IND Reports (zip – 330 MB) posted August 28, 2019

Section IV Descriptive Information – updated February 22, 2021
	Part 1 Descriptive Information (zip – 3.2 MB) **updated February 22, 2021**

Part 2 Clinical Reports (zip – 55 MB) posted August 28, 2019

Part 3 Published Literature (zip – 13 MB) posted August 28, 2019

Part 4 U.S. Government Publications (zip – 195 KB) posted August 28, 2019

Section V Labels – posted August 28, 2019
	Part 1 Labels (zip – 33 MB) posted August 28, 2019

Part 2 Consumer Perception (zip – 6.7 MB) posted August 28, 2019

Part 3 U.S. Government Publications (zip – 2.6 MB) posted August 28, 2019

Section VI Environmental Assessment – updated March 3, 2020
	Part 2 U.S. Government Publications (zip – 2.7 MB) posted August 28, 2019

Part 3 Public Interest Group Publication (zip – 343 KB) posted August 28, 2019

Section VII Research Findings – updated November 21, 2019
	Part 1 Summary of All Research Findings (zip – 343 KB) posted August 28, 2019

Part 2 Clinical Reports (zip – 370 MB) posted August 28, 2019

Part 3 Consumer Perception Reports (zip – 6.9 MB) updated November 21, 2019

Part 4 Population Modeling Reports (zip – 2.8 MB) posted August 28, 2019

Part 5 Published Literature (zip – 343 KB) posted August 28, 2019

Part 6 U.S. Government Publications(zip – 15 MB) posted August 28, 2019

Section VIII Scientific Studies and Analyses – updated October 26, 2020
	Part 1 Scientific Studies Analyses - Background Product Analysis (zip – 4.6 MB) updated October 26, 2020

Part 2 Scientific Studies - Non-Clinical (zip – 11 MB) posted October 1, 2019

Part 3 Scientific Studies - Population Modeling (zip – 8 MB) posted October 1, 2019

Section VIII Part 4 - Scientific Studies - Clinical – posted November 19, 2019
	Part 4.1 Scientific Studies - Clinical (zip – 12 MB) posted November 19, 2019

Part 4.2 Scientific Studies - Clinical (zip – 5 MB) posted November 19, 2019

Part 4.3 Scientific Studies - Clinical (zip – 523 MB) posted November 19, 2019

Part 4.4 Scientific Studies - Clinical (zip – 651 MB) posted November 19, 2019

Part 4.5 Scientific Studies - Clinical (zip – 279 MB) posted November 19, 2019

Part 4.6 Scientific Studies - Clinical (zip – 224 MB) posted November 19, 2019

Part 4.7 Scientific Studies - Clinical (zip – 225 MB) posted November 19, 2019

Part 4.8 Scientific Studies - Clinical (zip – 224 MB) posted November 19, 2019

Part 4.9 Scientific Studies - Clinical (zip – 256 MB) posted November 19, 2019

Part 4.10 Scientific Studies - Clinical (zip – 234 MB) posted November 19, 2019

Part 4.11 Scientific Studies - Clinical (zip – 217 MB) posted November 19, 2019

Part 4.12 Scientific Studies - Clinical (zip – 200 MB) posted November 19, 2019

Part 4.13 Scientific Studies - Clinical (zip – 95 MB) posted November 19, 2019

Part 4.14 Scientific Studies - Clinical (zip – 6 MB) posted November 19, 2019

Part 4.15 Scientific Studies - Clinical (zip – 1.5 MB) posted November 19, 2019

Part 4.16 Scientific Studies - Clinical (zip – 4 MB) posted November 19, 2019

Section VIII Part 5 - Scientific Studies - Consumer Perception – posted November 19, 2019
	Part 5.1 Scientific Studies - Consumer Perception (zip – 4 MB) posted November 19, 2019

Part 5.2 Scientific Studies - Consumer Perception (zip – 14 MB) posted November 19, 2019

Part 5.3 Scientific Studies - Consumer Perception (zip – 41 MB) posted November 19, 2019

Part 5.4 Scientific Studies - Consumer Perception (zip – 67 MB) posted November 19, 2019

Part 5.5 Scientific Studies - Consumer Perception (zip – 344 MB) posted November 19, 2019

Part 5.6 Scientific Studies - Consumer Perception (zip – 330 MB) posted November 19, 2019

Part 5.7 Scientific Studies - Consumer Perception (zip – 299 MB) posted November 19, 2019

Part 5.8 Scientific Studies - Consumer Perception (zip – 3 MB) posted November 19, 2019

Part 5.9 Scientific Studies - Consumer Perception (zip – 566 MB) posted November 19, 2019

Part 5.10 Scientific Studies - Consumer Perception (zip – 286 MB) posted November 19, 2019

Part 5.11 Scientific Studies - Consumer Perception (zip – 670 MB) posted November 19, 2019

Part 5.12 Scientific Studies - Consumer Perception (zip – 7.5 MB) posted November 19, 2019

Part 5.13 Scientific Studies - Consumer Perception (zip – 252 MB) posted November 19, 2019

Part 5.14 Scientific Studies - Consumer Perception (zip – 74 MB) posted November 19, 2019

Part 5.15 Scientific Studies - Consumer Perception (zip – 319 MB) posted November 19, 2019

Part 5.16 Scientific Studies - Consumer Perception (zip – 108 MB) posted November 19, 2019

Part 5.17 Scientific Studies - Consumer Perception (zip – 261 MB) posted November 19, 2019

Part 5.18 Scientific Studies - Consumer Perception (zip – 45 MB) posted November 19, 2019

Part 5.19 Scientific Studies - Consumer Perception (zip – 290 MB) posted November 19, 2019

Part 5.20 Scientific Studies - Consumer Perception (zip – 100 MB) posted November 19, 2019

Part 5.21 Scientific Studies - Consumer Perception (zip – 256 MB) posted November 19, 2019

Part 5.22 Scientific Studies - Consumer Perception (zip – 47 MB) posted November 19, 2019

Part 5.23 Scientific Studies - Consumer Perception (zip – 292 MB) posted November 19, 2019

Part 5.24 Scientific Studies - Consumer Perception (zip – 93 MB) posted November 19, 2019

Part 5.25 Scientific Studies - Consumer Perception (zip – 233 KB) posted November 19, 2019

Part 5.26 Scientific Studies - Consumer Perception (zip – 335 KB) posted November 19, 2019

Part 5.27 Scientific Studies - Consumer Perception (zip – 342 KB) posted November 19, 2019

Part 5.28 Scientific Studies - Consumer Perception (zip – 256 KB) posted November 19, 2019

Part 5.29 Scientific Studies - Consumer Perception (zip – 26 MB) posted November 19, 2019

Part 5.30 Scientific Studies - Consumer Perception (zip – 3.7 MB) posted November 19, 2019

Part 5.31 Scientific Studies - Consumer Perception (zip – 163 MB) posted November 19, 2019

Section IX All Documents Related to Research Findings – updated October 26, 2020
	Part 1 - All Documents Related to Research Findings (zip – 72 MB) updated October 26, 2020

Part 2 - All Documents Related to Research Findings  (zip – 43 MB) updated October 26, 2020

Part 3 - All Documents Related to Research Findings  (zip – 106 MB) posted October 26, 2020

Part 4 - All Documents Related to Research Findings  (zip – 197 MB) posted October 26, 2020

Part 5 - All Documents Related to Research Findings  (zip – 217 MB) posted October 26, 2020

Section X Postmarket Surveillance Program – posted October 29, 2019
	Part 1 Section X Postmarket Surveillance Program (zip – 229 KB) posted October 29, 2019Part 2 Clinical Study (zip – 12 MB) posted October 29, 2019Part 3 Published Literature (zip – 4 MB) posted October 29, 2019Part 4 Government and Public Interest Group Publications (zip – 31 MB) posted October 29, 2019

Amendments – updated April 8, 2020
	March 10, 2020 Amendment:  Correction to Tables VI.F-1, VI.G-1 and VI.G-2 in Section VI. Environmental Assessment (zip – 263 KB) posted **April 8, 2020**March 2, 2020 Amendment: Submission of Tabular Index of Referenced Citations (zip – 150 KB) posted****March 16, 2020September 13, 2019 Amendment: Response to September 9, 2019, FDA Information Request (zip – 3 MB) posted January 28, 2020August 28, 2019 Amendment: Response to August 26, 2019, FDA Information Request (zip – 1.5 MB) posted October 29, 2019August 7, 2019 Amendment: Response to August 2, 2019, FDA Information Request (zip – 18 MB) posted December 23, 2019July 18, 2019 Amendment: Submission of 6-week Clinical Study Part One (zip – 81 MB) posted December 23, 2019July 18, 2019 Amendment: Submission of 6-week Clinical Study Part Two (zip – 7 MB) posted December 23, 2019June 25, 2019 Amendment: Submission of 12-month Storage Stability and Water Activity Study Results (zip – 7 MB) posted October 29, 2019May 23, 2019 Amendment: Update to Section V. Labels, Labeling, and Advertising (zip – 800 MB) posted October 29, 2019

**Note:** *The FDA is required by section 911(e) of the Federal Food Drug & Cosmetic Act, as amended by the Tobacco Control Act, to make MRTP applications available to the public (except for matters in the application that are trade secrets or otherwise confidential commercial information) and to request comments on the information contained in the applications and on the label, labeling, and advertising accompanying the applications.*

Additional Resources

FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them
	FDA permits sale of two new reduced nicotine cigarettes through premarket tobacco product application pathway
	Perspective: Lessons Learned from the First Review of Modified Risk Tobacco Product (MRTP) Applications
	Tobacco Products Scientific Advisory Committee: February 2020 Meeting Materials
	TPSAC Meetings on MRTP Applications
	MRTP overview

                                                                                  Content current as of:
      12/23/2021
              
              
Regulated Product(s)
		 TobaccoAdvertising and Promotion

          
                        Modified Risk Tobacco Products
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop